Amazon cover image
Image from Amazon.com

The $800 million pill : the truth behind the cost of new drugs / Merrill Goozner.

By: Material type: TextTextPublication details: Berkeley : University of California Press, ©2004.Description: 1 online resource (297 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780520939288
  • 052093928X
  • 1417510625
  • 9781417510627
  • 1597344508
  • 9781597344500
  • 1282358243
  • 9781282358249
Other title:
  • Eight hundred million dollar pill
Subject(s): Additional physical formats: Print version:: $800 million pill.DDC classification:
  • 338.4/3/61510973 22
LOC classification:
  • RS100 .G668 2004eb
NLM classification:
  • 2004 E-244
  • QV 736
Online resources:
Contents:
Introduction; PART ONE: BIOHYPE; 1 The Longest Search; 2 Rare Profits; 3 The Source of the New Machine; PART TWO: DIRECTED RESEARCH; 4 A Public-Private Partnership; 5 The Divorce; 6 Breakthrough!; 7 The Failed Crusade?; PART THREE: BIG PHARMA; 8 Me Too!; 9 The 800 Million Pill; 10 The Future of Drug Innovation; Notes; Bibliography; Acknowledgments; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z.
Summary: "Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
eBook eBook e-Library EBSCO Medical Available
Total holds: 0

Includes bibliographical references (pages 281-283) and index.

"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket

Print version record.

Introduction; PART ONE: BIOHYPE; 1 The Longest Search; 2 Rare Profits; 3 The Source of the New Machine; PART TWO: DIRECTED RESEARCH; 4 A Public-Private Partnership; 5 The Divorce; 6 Breakthrough!; 7 The Failed Crusade?; PART THREE: BIG PHARMA; 8 Me Too!; 9 The 800 Million Pill; 10 The Future of Drug Innovation; Notes; Bibliography; Acknowledgments; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z.

Added to collection customer.56279.3

Powered by Koha